These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 38941393)
1. Mendelian randomization as a cornerstone of causal inference for gut microbiota and related diseases from the perspective of bibliometrics. Wang J; Li J; Ji Y Medicine (Baltimore); 2024 Jun; 103(26):e38654. PubMed ID: 38941393 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 signaling pathway in Mendelian randomization: A 10-year bibliometric analysis. Jing S; Wang J; Yang S; Wu H Medicine (Baltimore); 2024 Apr; 103(14):e37507. PubMed ID: 38579070 [TBL] [Abstract][Full Text] [Related]
3. Bibliometric and visual analysis of intestinal flora and immunity. Nie K; Deng T; Wang J; Qi L; Liu N; Chen Z; Xia L Medicine (Baltimore); 2024 Jan; 103(4):e36575. PubMed ID: 38277560 [TBL] [Abstract][Full Text] [Related]
4. Using Mendelian randomization as the cornerstone for causal inference in epidemiology. Xu J; Li M; Gao Y; Liu M; Shi S; Shi J; Yang K; Zhou Z; Tian J Environ Sci Pollut Res Int; 2022 Jan; 29(4):5827-5839. PubMed ID: 34431050 [TBL] [Abstract][Full Text] [Related]
5. Research trends on the relationship between gut microbiota and colorectal cancer: A bibliometric analysis. Wu W; Ouyang Y; Zheng P; Xu X; He C; Xie C; Hong J; Lu N; Zhu Y; Li N Front Cell Infect Microbiol; 2022; 12():1027448. PubMed ID: 36699721 [TBL] [Abstract][Full Text] [Related]
6. Bibliometrics and visual analysis of metformin and gut microbiota from 2012 to 2022: A systematic review. Shu Y; Li W; Hu Q; Xiong D Medicine (Baltimore); 2023 Dec; 102(50):e36478. PubMed ID: 38115325 [TBL] [Abstract][Full Text] [Related]
7. Bibliometric analysis of intestinal microbiota in diabetic nephropathy. Gao LW; Yang XY; Yu YF; Yin S; Tong KK; Hu G; Jian WX; Tian Z Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8812-8828. PubMed ID: 37782191 [TBL] [Abstract][Full Text] [Related]
8. Bibliometric analysis of the 100 most-cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021. Wan C; Kong X; Liao Y; Chen Q; Chen M; Ding Q; Liu X; Zhong W; Xu C; Liu W; Wang B Clin Exp Med; 2023 Oct; 23(6):2759-2772. PubMed ID: 36522553 [TBL] [Abstract][Full Text] [Related]
9. The interaction between microbiota and immune in intestinal inflammatory diseases: Global research status and trends. Liu C; Su W; Tan Z; Zhang J; Dong W Front Cell Infect Microbiol; 2023; 13():1128249. PubMed ID: 36824689 [TBL] [Abstract][Full Text] [Related]
10. Revealing the link between gut microbiota and brain tumor risk: a new perspective from Mendelian randomization. Yang J; Lu J; Dong Y; Wei Y; Christian M; Huang J; Kuang H; Cao D Front Cell Infect Microbiol; 2024; 14():1404745. PubMed ID: 39165915 [TBL] [Abstract][Full Text] [Related]
11. Causal Effects of Specific Gut Microbiota on Chronic Kidney Diseases and Renal Function-A Two-Sample Mendelian Randomization Study. Li N; Wang Y; Wei P; Min Y; Yu M; Zhou G; Yuan G; Sun J; Dai H; Zhou E; He W; Sheng M; Gao K; Zheng M; Sun W; Zhou D; Zhang L Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678231 [TBL] [Abstract][Full Text] [Related]
12. Global research progress of gut microbiota and epigenetics: bibliometrics and visualized analysis. Tian S; Chen M Front Immunol; 2024; 15():1412640. PubMed ID: 38803501 [TBL] [Abstract][Full Text] [Related]
13. Advances in gut microbiome in metabonomics perspective: based on bibliometrics methods and visualization analysis. Wang J; Dong P; Zheng S; Mai Y; Ding J; Pan P; Tang L; Wan Y; Liang H Front Cell Infect Microbiol; 2023; 13():1196967. PubMed ID: 37325519 [TBL] [Abstract][Full Text] [Related]
14. Exploring causal effects of gut microbiota and metabolites on body fat percentage using two-sample Mendelian randomization. Wang X; Lu C; Li X; Ye P; Ma J; Chen X Diabetes Obes Metab; 2024 Sep; 26(9):3541-3551. PubMed ID: 38828839 [TBL] [Abstract][Full Text] [Related]
15. Global research trends in regulating gut microbiome to improve type 2 diabetes mellitus: bibliometrics and visual analysis. Jiang R; Cong Z; Zheng L; Zhang L; Guan Q; Wang S; Fang J; Chen J; Liu M Front Endocrinol (Lausanne); 2024; 15():1401070. PubMed ID: 38887274 [TBL] [Abstract][Full Text] [Related]
16. Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis. Yang S; Yu D; Liu J; Qiao Y; Gu S; Yang R; Chai X; Wang W Front Endocrinol (Lausanne); 2023; 14():1121540. PubMed ID: 36967792 [TBL] [Abstract][Full Text] [Related]
17. The Effects of Specific Gut Microbiota and Metabolites on IgA Nephropathy-Based on Mendelian Randomization and Clinical Validation. Wang F; Li N; Ni S; Min Y; Wei K; Sun H; Fu Y; Liu Y; Lv D Nutrients; 2023 May; 15(10):. PubMed ID: 37242290 [TBL] [Abstract][Full Text] [Related]
18. Application of Mendelian randomization in the discovery of risk factors for coronary heart disease from 2009 to 2023: A bibliometric review. Zhong D; Cheng H Clin Cardiol; 2024 Jan; 47(1):e24154. PubMed ID: 37724687 [TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and eye diseases: a bibliometric study and visualization analysis. Fu X; Tan H; Huang L; Chen W; Ren X; Chen D Front Cell Infect Microbiol; 2023; 13():1225859. PubMed ID: 37621873 [TBL] [Abstract][Full Text] [Related]
20. Causal relationship between gut microbiota, plasma metabolites, inflammatory cytokines and abdominal aortic aneurysm: a Mendelian randomization study. Li C; Liu Z; Yang S; Li W; Liang B; Chen H; Ye Y; Wang F; Liu X; Jiang Y; Wu H; Peng Y; Meng Z Clin Exp Hypertens; 2024 Dec; 46(1):2390419. PubMed ID: 39133866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]